Monte Rosa Therapeutics H-1B Visa Sponsorship 2026
Pharma & biotech · H-1B sponsor · FY2017–2026
🏢 Boston, MA HQ🌐 monterosatx.com
Does Monte Rosa Therapeutics sponsor H-1B visas?
Yes. Monte Rosa Therapeutics has filed 10 H-1B LCAs with the U.S. Department of Labor between FY2020 and FY2026. In FY2025–2026 Monte Rosa Therapeutics filed 4 H-1B LCAs at a median base salary of $146,970, about 21% above the national H-1B median of $121,966 for the same period. No PERM green-card cases are on record.
Boston, MA accounts for 90% of its H-1B filings.
H-1B pay & filings by year
Median base salary (line) and H-1B filing volume (bars), by fiscal year
Show the numbers behind this chart
| Fiscal year | H-1B LCA filings | Median base salary |
|---|---|---|
| FY2026 (partial) | 2 | $147k |
| FY2025 | 2 | $124k |
| FY2024 | 1 | $136k |
| FY2022 | 4 | $126k |
| FY2020 | 1 | $152k |
A fiscal year marked partial is still in progress, so its total is lower than a complete year and the two are not comparable.
H-1B wage floor & filing outcomes
What this employer pays against the DOL legal minimum, how senior the roles are, and how the filings were decided
Roles they file for
Where they hire
Worker backgrounds
From green-card (PERM) cases
Sponsors H-1B workers but has few or no green-card (PERM) cases under this name, so worker backgrounds aren’t available.
Pay against the local market
Monte Rosa Therapeutics’s most-filed occupations and metros, FY2024–FY2026. Its median base salary is 111% of the local BLS median for the same work.
| Occupation | Metro | Filings | Monte Rosa Therapeutics pay | Local BLS median‡ | vs market |
|---|---|---|---|---|---|
| Biological Scientists, All Other | Boston, MA | 2 | $146,970 | $103,120 | 143% |
| Medical Scientists | Boston, MA | 1 | $136,000 | $129,230 | 105% |
| Computer Hardware Engineers | Boston, MA | 1 | $148,427 | $170,570 | 87% |
| Biochemists and Biophysicists | Boston, MA | 1 | $100,152 | $127,510 | 79% |
About Monte Rosa Therapeutics
Monte Rosa Therapeutics is a pharma & biotech company based in Boston, MA. It is listed on Nasdaq as GLUE.
- Legal name
- Monte Rosa Therapeutics, Inc.
- Listed
- Nasdaq: GLUE
- Incorporated in
- Delaware
- Headquarters
- 321 Harrison Avenue, Boston, MA 02118
- Industry
- Pharma & biotech
- Website
- monterosatx.com
- Revenue FY2025
- $124M +64% from $76M
- Net income FY2025
- $-39M +47% from $-73M
- R&D FY2025
- $142M (114% of revenue)
H-1B sponsors similar to Monte Rosa Therapeutics
| Employer | Filings, all years | Recent filings | Median base | New employment | Level III-IV roles |
|---|---|---|---|---|---|
| Asahi Kasei Bioprocess America | 11 | 4 | $84k | 0 | — |
| Deepcell | 11 | 3 | $149k | 1 | — |
| Dyno Therapeutics | 11 | 2 | $138k | 0 | — |
| Monte Rosa Therapeutics | 10 | 4 | $147k | 2 | — |
| DNA Script | 10 | 3 | $137k | 0 | — |
| Oxford Biomedica | 10 | 3 | $122k | 2 | — |
| Prelude Therapeutics | 10 | 2 | $97k | 1 | — |
